SHYAMSHREE MANNA

SHYAMSHREE MANNA

Professor

Creative, hard-working, enthusiastic, and detail-oriented.

About

10 Oct , 1979

10 Jan , 2018

M. Pharm – Pharmacology

NEUROSCIENCE, NEUROPSYCHOPHARMACOLOGY, ETHNOPHARMACOLOGY, BIOANALYTICAL TECHNIQUES

Studies in our lab are instigated at the level involving neurotransmission/receptor activity, bio-chemical processes, and neural circuitry to understand the neuromodulation of neuropeptides or endocannabinoids on affective disorders, epilepsy, pain and addiction using animal models. Studies on underlying mechanism of functional foods for reducing the neuropsychiatric disorders mainly anxiety, depression and addiction are being carried out. In addition our lab is interested in repurposing of drug molecules in stress-related psychiatric disorders including depression and anxiety.

Qualifications

Educational Qualifications

  • Ph. D.
    UNIVERSITY DEPARTMENT OF PHARMACEUTICAL SCIENCES, RTM NAGPUR UNIVERSITY - 2013
  • M.PHARM
    UNIVERSITY DEPARTMENT OF PHARMACEUTICAL SCINCES, RTM NAGPUR UNIVERSITY - 2005

Teaching and R&D experience

Experience Years
TEACHING 15 years
R & D 1.5 years
RESEARCH 16 years

Courses Taught

  • B. Pharm
  • M. Pharm – Pharmacology

Activities

Awards & Recognitions

• Appointed Chairperson of Poster session at 50th Annual Conference IPS 2018, Mumbai. • Six weeks certificate course on Electrophysiological & Neuroimaging Studies including Mathematical Modelling offered by Center with Potential for Excellence in Particular Area, Calcutta University • Senior Research Fellowship (SRF) for Doctoral studies in Pharmaceutical Sciences , By Council of Scientific and Industrial Research (CSIR), HRD ministry, Govt of India. (2010-2012). • Junior Research Fellowship (JRF) for Doctoral studies in Pharmaceutical Sciences, By University Grant Commission, Govt. of India (2008-2010). • Junior Research Fellowship (JRF) for Post Graduate Studies in Pharmacy, By University Grant Commission, Govt. of India (2003- 2005). • Passed GATE (GRADUATE APTITUDE TEST FOR ENGINEERING) 2003 with 98.16 percentile, all INDIA rank 240. • 2nd Best Paper (selected from 400 papers) in CSIR young Scientist Category in 42nd International Indian Pharmacological Society Conference, 2009; Kolkata. • 1st in National Seminar on Recent trends in Pharmaceutical Sciences, 2013 at Himalayan Pharmacy Institute, Sikkim. • Paper was selected for Achari Prize session at International Pharmacological Conference, 2004, Kolkata.

Online Mode Of Teaching

ZOOM, GOOGLE CLASS ROOM, MEET

Expertise

Technical skills • Blood collection: Retro orbital plexus, tail vein • Stereotaxic surgery for cannaula implantation in rodent brain • Jugular vein cannulation • Administration of drugs: Per Oral, IV, IP, IM, SC, ICV (Intracerebroventricular) and Inhalant anesthesia • Isolated tissue experiments: Ileum, jejunum, uterus and fundus • Olfactory bulbectomy, adrenalectomy, ovariectomy in rodents ANIMAL MODELS: DEPRESSION; ANXIETY, COGNITION MODELS , ADDICTION

Membership of professional bodies

LIFE MEMBER OF INDIAN PHARMACOLOGICAL SOCIETY; MEMBER OF INTERNATIONAL CANNBINOID RESEARCH SOCIETY

Publications

Publication Impact Factor Journal
An observational study report on Adverse Drug Reactions of a combination of drugs in a tertiary care hospital,
Barriers leading to treatment delay in breast cancer patients: A demographic survey in speciality government hospital at Kolkata.
Paracetamol potentiates antidepressant and anticompulsive like effects of fluoxetine in mice. 3
A possible participation of transient receptor potential vanilloid type 1 channels in the antidepressant effect of fluoxetine. 3
Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures. 2
Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor. 5
Transient receptor vanilloid type 1 channels modulate the anxiolytic effect of diazepam. 3
Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. 3
Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors. 4
A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol. 2

Participations

Participation In Seminar / Conference / Symposium / Workshop / Discussion Meeting

SL. No. Participations
1. • Reversing roles for cannabinoid receptor type-1 (CB1) and transient receptor potential vanilloid type-1 channel (TRPV1) in the neuroleptic and cataleptic effects of haloperidol, selected for Scientific Poster Session on March 23, 2016 at the Marijuana and Cannabinoids: A Neuroscience Research Summit being sponsored by the National Institutes of Health, Bethesda, MD 20814 .
2. • Paracetamol: beyond antipyresis and analgesia. National Seminar on Recent Advancement in Pharmaceutical Development and Technology in India at Bengal College of Pharmaceutical Sciences, Durgapur, 26th November, 2016.
3. • Shilajit attenuates compulsive and depressive-like effects in mice. National Seminar at Bengal College of Pharmaceutical Sciences, Durgapur, 14th April 2015.
4. • Anandamide attenuates compulsive behavior in mice. National Seminar at National Seminar at Jadavpur University IAPST, 14th Dec 2013.
5. • CB1 receptor activation antagonizes fluoroquinolone-induced seizures In mice. National Seminar on Modern Trends In Pharmaceutical Sciences, 8-9th August, 2013 at Himalayan Pharmacy Institute, Sikkim, India

Participation In Administrative Committees

SL. No. Participations
1. IAEC-SECRETARY
2. ICC- CHAIRPERSON
3. DISCIPLINE COMMITTEE- MEMBER
4. MEMBER OF ACADEMIC COUNCIL

Project Guidance

No Data Available